Positivity of HER-2/neu has been seen previously in high grade Endometrioid carcinoma and serous carcinoma.16 In a study by Slomovitz et al,16 18% of Serous carcinomas over expressed HER-2/neu by immunohistochemistry. This evidence concerns the gene ERBB2 and endometrioid adenocarcinoma.